BYDUREON
2MG INJ PLQ SUS PRO 12(3X4)+3J
SÚKL code | 0210104 |
---|---|
Name of the product | BYDUREON |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | BYDUREON |
Supplement | 2MG INJ PLQ SUS PRO 12(3X4)+3J |
Strenght | 2MG |
Pharmaceutical form | Powder and solvent for prolonged-release suspension for injection |
Package | 12(3X4)+3J |
Route | Subcutaneous use |
Wrap type | Pre-filled pen |
Legal status | na lékařský předpis |
Active substance | EXENATIDE (EXENATIDUM) |
ATC group | A10BJ01 |
ATC group name | EXENATID |
Marketing authorisation information
Registration Number | EU/1/11/696/004 |
---|---|
Type of MA | centralised without orphans |
MA status | R - active MA/authorised medicinal product |
MA Holder | AstraZeneca AB, Södertälje |
MA Holder country | ŠVÉDSKO |